SYNCERUS S A R L has a total of 12 patent applications. It decreased the IP activity by 66.0%. Its first patent ever was published in 2017. It filed its patents most often in Australia, Brazil and Canada. Its main competitors in its focus markets measurement and biotechnology are ANSH LABS LLC, MCBI KK and IMUSYN GMBH & CO KG.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 1 | |
#2 | Brazil | 1 | |
#3 | Canada | 1 | |
#4 | Chile | 1 | |
#5 | China | 1 | |
#6 | Colombia | 1 | |
#7 | EPO (European Patent Office) | 1 | |
#8 | Israel | 1 | |
#9 | Republic of Korea | 1 | |
#10 | Mexico | 1 | |
#11 | Singapore | 1 | |
#12 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Measurement | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Floch Jean-François | 5 |
#2 | Floch Jean-Francois | 3 |
#3 | Floch Jean Francois | 1 |
#4 | Jean-Francois Floch | 1 |
#5 | Jean- François Floch | 1 |
#6 | Jean-François Floch | 1 |
Publication | Filing date | Title |
---|---|---|
CN108700586A | Composition and method for the risk for assessing cancer generation |